TransCelerate BioPharma Launches Three New Initiatives and Expands Membership

TransCelerate announced it has committed to an expansion of its clinical and drug safety portfolio, revealing three new initiatives: the Common Clinical Serious Adverse Events Fields Initiative, the Modernization of Data Analytics for Clinical Development Initiative and the Interpretation of Guidances and Regulations Initiative.

Translate ยป
X

Stay Connected to TransCelerate.